ICIs Are Effective in the Treatment of Older Adults With mRCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy of Immune-Checkpoint Inhibitors (ICI) in the Treatment of Older Adults With Metastatic Renal Cell Carcinoma (mRCC) — An International mRCC Database Consortium (IMDC) Analysis
J Geriatr Oncol 2021 Mar 02;[EPub Ahead of Print], DV Araujo, JC Wells, AR Hansen, N Dizman, SK Pal, B Beuselinck, F Donskov, CL Gan, F Yan, B Tran, CK Kollmannsberger, G de Velasco, T Yuasa, MN Reaume, DS Ernst, T Powles, GA Bjarnason, TK Choueiri, DYC Heng, S DudaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.